It was a pleasure to catch up with our Editorial Board member, Prof. Anat Loewenstein (Tel Aviv Medical Center, Israel), who talked to us about the importance of home monitoring in wet age-related macular degeneration.
- How has the COVID-19 pandemic affected the management of patients with wet age-related macular degeneration (AMD)? (0:10)
- How can home monitoring of visual changes improve the monitoring of wet AMD? (02:36)
- Could you tell us a little about home optical coherence tomography (OCT) technology and its ease of use in elderly populations? (03:36)
- Could you give us an overview of the study of home OCT that you are leading? (04:37)
- What other promising remote monitoring systems are emerging? (05:40)
Speaker Disclosure: Prof. Anat Loewenstein discloses the following: consultant for: Allergan, Bayer, Novartis, Notal – vision, Syneos health, beyeonics surgical, Roche, Pres-By, Xbran, WebMD, KHB, Oxurion.
Support: Interview and filming supported by Touch Medical Media Ltd.
Filmed in coverage of EURETINA 2020.
Share this Video
Related Videos In Macular Degeneration
Carl Regillo, Hawaiian Eye 2022: Emerging Therapies for Wet Age-related Macular Degeneration
There are new treatment options for patients with wet age-related macular degeneration emerging, according to a presentation at Hawaiian Eye 2022. It was a pleasure to speak with Dr Carl Regillo (Thomas Jefferson University, Philadelphia, PA, USA) about his views on the latest treatments to emerge for wet age-related macular degeneration. The abstract entitled Update […]
Carl Regillo, Hawaiian Eye 2022: Ranibizumab Injection for the Treatment of Wet Age-related Macular Degeneration
A new ranibizumab injection offers hope for patients with wet age-related macular degeneration, according to a presentation at Hawaiian Eye 2022. It was great to catch up with Dr Carl Regillo (Thomas Jefferson University, Philadelphia, PA, USA), who talked to us about the ranibizumab injection and its advantages over anti-vascular endothelial growth factor injections. The […]
Kyoko Ohno-Matsui, EURETINA 2021: Advantages and Limitations of a Deep Learning Algorithm
We were delighted to speak with Kyoko Ohno-Matsui (Tokyo Medical and Dental University, Tokyo, Japan) about the potential advantages and limitations of a deep learning algorithm for automated detection of myopic maculopathy and pathologic myopia in fundus images, and the challenges in developing this algorithm. Questions What are the potential advantages and limitations of a […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!